Peptide record

TPDB20348

Antibacterial Anticancer Antiviral standard
15 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB20348
Antibacterial Anticancer Antiviral
Anti-infective peptides Cancer-related peptides
Peptipedia AI4AVP dbAMP 3.0 DRAVP 2.0
standard
No
A 15-aa standard-residue multi-activity (Antibacterial, Anticancer, and Antiviral) peptide sequence curated from Peptipedia, AI4AVP, dbAMP 3.0, and other sources, with an available 3D structural model.
Sequence
GLLHLHQNIVDVQYM
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C80H126N22O22S1
ARCEKFPSTW
L
1780.07
6.01
2
1
8
-1
0.32
0.273
142.67
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
1490
0.84
4
Residue Composition
number
0
A
0
R
1
N
1
D
0
C
0
E
2
Q
1
G
2
H
1
I
3
L
0
K
1
M
0
F
0
P
0
S
0
T
0
W
1
Y
2
V
Amino Acid Distribution
A: 0 R: 0 N: 1 D: 1 C: 0 E: 0 Q: 2 G: 1 H: 2 I: 1 L: 3 K: 0 M: 1 F: 0 P: 0 S: 0 T: 0 W: 0 Y: 1 V: 2
Chemical Descriptors
15 reviewed residue count
C80H126N22O22S1 sequence-only estimate (linear, free termini)
1780.07 sequence-only estimate (linear, free termini)
6.01 sequence-only estimate (linear, free termini)
-1 sequence-only estimate (linear, free termini)
0.32 sequence-only estimate (linear, free termini)
0.273 sequence-only estimate (linear, free termini)
Evidence Records 1 records
Evidence 1 Activity

Source & Reference

dbAMP 3.0 DRAVP 2.0